Nuzenio

Qncx

Qncx news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 4 publisher sources 100/100 entity strength

Latest news

Timeline

Wed, 05 Aug 2026 10:31:10 GMTQuince Therapeutics (QNCX) updates S-3 shelf with legal opinion and $498K in costs - Stock Titan
Tue, 04 Aug 2026 19:07:14 GMTQuince Therapeutics (QNCX) sees Squadron group report 5.6% ownership stake - Stock Titan
Tue, 04 Aug 2026 11:00:19 GMTQNCX Q2'26 Earnings: revenue estimate is 0 USD - TradingView
Sat, 01 Aug 2026 03:22:30 GMTQNCX Stockholders Plan to Sell 15.47M Shares Amid Unprofitable B - GuruFocus
Fri, 31 Jul 2026 07:00:00 GMTQuince Therapeutics (QNCX) seeks approval for Orphai merger dilution and $115M PIPE - Stock Titan
Wed, 29 Jul 2026 17:27:47 GMTQNCX Initiated by Oppenheimer -- Rating Set to Outperform with $82 Target - GuruFocus

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Qncx.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.